Loading company…
Trevena develops biopharmaceutical treatments for central nervous system disorders and pain.
Trevena develops medicines for central nervous system disorders, including OLINVYK injection for acute pain and investigational candidates for diabetic neuropathic pain, epilepsy, migraine, and opioid use disorder. Founded in 2007, the company is based in the US. It raised USD 64.75 mn in its January 2014 IPO and USD 45 mn in a private placement in December 2014.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in